Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope - no evidence KN has become deeply immersed in the other issues with which BIEL's new CEO will have to exhibit leadership, and no reason to burden your sales/distribution star with those issues, thereby reducing his focus on those sales and relationships.
Hmmm... what does KN know about manufacturing? SEC rules/requirements? Market uplisting? Equities? Etc., etc., etc. Sorry, sales is not all there is to being a successful CEO. I think KN is great, but I don't see a natural CEO fit.
Again, to be successful it would be great to get someone with CEO experience, or at least close to that, within the vertical. We will see what pans out.........
I never agreed with those who wanted KN to be CEO; I would prefer he stick to his strength, which is sales. There is zero evidence that he has what it takes to undertake the CEO role (none against it either, but again, I would prefer he stick to sales and distribution).
The other choices aren't 'naturals' either necessarily. What BIEL needs is a competent and experienced CEO with previous successes under his/her belt, preferably in the same vertical. Sadly, BIEL cannot likely afford that kind of talent.
Agreed. Will be very interesting to observe. Given her history with IBEX, the SEC, and her experience profiting via loans and the dilution machine, I would say that's not a promising start.
It would be nice to have an outsider with experience in the space, but I think that is beyond reach in terms of affordability.
I share the sentiment, as I am not inclined to believe she will be a worthy CEO. I suspect we will find out soon enough.
I would bet money on Kelly Whelan taking over leadership.....time till tell.
I hate to chase good money after bad, but I am at least thankful that total, woeful mismanagement has garnered many short-term flipping profits, particularly in light of Andy's continued ability to push shares onto the public (a shame he can't sell the products as effectively, isn't it?).
Products are fine - even great - sadly that does not matter if management is inept (and unethical apparently, just ask the SEC). ActiPatch could cure cancer and I doubt whether Andy would be able to move the product even then. He would likely kill any prospective money-making deals as he so ludicrously did with CVS.
The landscape is littered with exceptional products whose companies are long gone due to similar ineptitude. Good products are not enough, and that's why BIEL continues to trade in the trips we are constantly told cannot last (but do last, and last, and last.....).
Thanks for your complete incompetence Andy- while we are at it, thanks for the SEC violation and fines as well!!!! ROFL
No issues. Ignore the realities of supply and demand along with market trading, etc.
BTW - on market cap, BIEL is at present overbought.
Specious reply, as Apple does not have trillions of shares, and in nothing like BIEL in any way.
LOL - ok, please ignore all the dilution, horrid share structure, and the impact of both on trading and profit taking...Go right ahead!!! LOL
Thanking an incompetent CEO is no different than thanking anyone else who has destroyed a company and it's potential value, hence the appropriate references.
Hope everyone enjoyed the paid for interview Andy bumbled through.
Market cap is one thing; share structure and its impact on actual trading is something else, which market cap does not address, and which plays out every single time BIEL has a positive run. Simply observe the patterns of the last three runs, and anticipate the next installment.
On the topic of market cap, all these predictions of copper and silver are ludicrous; BIEL isn't worth anywhere near either of those territories.
Again, hilarious. Thanks Andy!! Thanks Bernie Madoff!! Thanks ENRON!!! Thanks Bernie Ebbers!!!
No worries, sevens will return as they always do. Very predictable stock. I look forward to full FDA approval and the generous spike that will result - until flippers and profit makers take advantage of the abysmal share structure and drive it right back to trips just like the last two times!!!!
BIEL - predictable as ever.
I firmly believe in triple zeroes - it represents a reasonable valuation.
The products aren't the issue; without a change in leadership, nothing is going to improve. CE mark lost; deferred revenue which cannot be posted; endless discussions with few deals, and the deals in place do not produce sales; killing a 9,000 store CVS deal. Trips are quite believable.
Big deal; have seen that action repeatedly, and then the PPS backing down to .0007./.0008. Meaningless churn, nothing more.
Again, unbelievable. It's like sending a thank you note to Bernie Ebbers.
Agreed - and I cannot imagine a single new investor being encouraged to buy shares after listening to the 'interview'. More likely, anyone unfamiliar with BIEL would have tuned out within the first five minutes, if not sooner.
Total Debacle, as usual.
It was well over 20 minutes of pure embarrassment, as a paid for shill promotion no less. Awful - no other word to describe it.
The opportunities to purchase shares in triple zeroes are endless, as they have been for many, many years; all thanks to Andy's ongoing and incompetent leadership.
Not only was it awful, but it was a 'paid for' promotion. Another waste of money by BIEL management. That 'interview' won't induce a single new investor to purchase BIEL shares.
The coming year shows no inclination to be any different than previous years. The legal side of the opiod crisis would present some opportunity for an experienced and competent leader; unfortunately, BIEL does not possess a leader in that category.
Keith is no longer a new addition; he has brought players to the table for which the subsequent possible deals were destroyed by the CEO. I don't see that changing as it has been a part of AW's DNA. The deals that have been consummated have brought little to nothing in terms of significant revenue.
Keep in mind that Keith does not even list himself as VP of Sales for BIEL on his LinkedIn account; he remains an independent representative for multiple products in this space.
Walmart? Yeah, is AW thought the margins weren't good on the CVS effort, he will hate Wally World.
The positives are irrelevant with current leadership in place.
What difference does the efficacy of the products make, when the CEO repeatedly missteps and captains the ship into the reef? Absolutely none.
He blew it letting the CE mark expire. He can't even get the deferred revenue on the books due to his continued incompetence (you know, the $500+K that was 'guaranteed' to book in Q1....). He blew it with the CVS roll out - recall all the excitement over the expanded store launch from the original 200 stores to 400 units? Ah, the endless euphoria that was expressed daily while the numbers rolled in and every new store was identified and categorized. Well, how many CVS stores are currently carrying BIEL products? Zero. Zilch. Nada. Thanks AW!!!
B. Braun was to rake in millions in sales, right? Never happened, and rarely discussed anymore. Another lost opportunity when he pulled product from Boots.
Failure after failure. It's Q4 2019 and it's the same song and dance we have been hearing since 2015....it never changes, and with Andy at the helm it never will. BIEL products could cure cancer and Andy still coulnd't figure out a way to sell them.
Horrendously boring interview with a CEO who remains unable to pronounce 'opioids' correctly. Can't imagine potential investors lasting past the five minute mark of this mumbling monologue. Unbelievable. If you are going to pay for one of these cheesy interviews, at least make it listenable.
Meanwhile, the shareholder update is more of the same...working on ISO renewal, working on remaining items for CE mark, working on partnerships. Whatever partnerships are in place at the moment, they have done nothing for sales, which remain as pathetic as the PPS.
It's now the fourth quarter of 2019, and virtually no progress has been made while the PPS continues to languish. The BIEL train not only hasn't left the station, it's not even on the tracks. Same story year after year after year....As for the FDA, it isn't even past the administrative processing point. So much for predictions of approval 'around the corner'.
Time to start the new chorus: '2020 will be the year of BIEL'. Same song and dance since 2015 - with the same negligible results. Way to go Andy - when you killed the CVS deal you essentially destroyed any chances for a recovery in 2019. Nice work.
OK, so we will conveniently forget the extended hoopla and euphoria that took place when the CVS test run of 200 stores expended to 400 and sales were supposedly going so well that a full store roll out was inevitable, correct?
Hilarious.
Wal-Mart isn't really selling the product, is it? Wal-Mart isn't carrying stock or purchasing any ActiPatches and stocking them and selling them in the way their brick and mortar stores do- it's an entirely different scenario allowing sales through their web presence. Watch and see what happens IF (and it's a HUGE if) Wal-Mart negotiates an in-store deal.
Regardless, nobody can make a credible case for busting a 9,000 store deal - it's complete and utter incompetence.